COPD Drug Developed by Regeneron, Sanofi Fails Key Test

investopedia.com/copd-drug-developed-by-regeneron-sanofi-fails-key-test-11745193

Key Takeaways
- A COPD treatment for former smokers developed by Regeneron Pharmaceuticals and Sanofi failed to meet its primary endpoint in one Phase 3 trial.
- A second test of the drug, itepekimab, was successful.
- The news sent shares of Regeneron Pharmaceuticals to a four-year…

This story appeared on investopedia.com, 2025-05-30 17:07:28.074000.
The Entire Business World on a Single Page. Free to Use →